Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Basic Information
- Category: Pharmaceuticals & Healthcare
- Founded: 2002
- Headquarters: Cambridge, MA
- Website: https://www.alnylam.com
Documented Facts
- Founded: 2002 (No linked source recorded for this statement.)
- Headquarters: Cambridge, MA (No linked source recorded for this statement.)
- Category: Pharmaceuticals & Healthcare (No linked source recorded for this statement.)
- Email: medinfo@alnylam.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- Stock ticker: ALNY (Nasdaq) (No linked source recorded for this statement.)
Products and Services
- Alnylam Pharmaceuticals Products: American biopharmaceutical company.
Evidence and Sources
- Official Website (Primary Source)
- Alnylam Pharmaceuticals on instagram (social)
- Alnylam Pharmaceuticals on facebook (social)
- Alnylam Pharmaceuticals on linkedin (social)
- Alnylam Pharmaceuticals — Wikipedia (reference)
- ALNYLAM PHARMACEUTICALS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Pharmaceuticals & Healthcare profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Alnylam Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/alnylam-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/alnylam-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/alnylam-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-01
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Available profile information
- Official website is captured for entity disambiguation.
- 6 supporting sources linked.
- 6 structured facts available for extraction.
- 1 product or service signal captured.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.